NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nomic Bio

Nomic Bio

Private
MontrealHealthcare & Life Scienceshttps://nomic.bio/

Last Round

Series B

Sep 17, 2024

Total Funding Raised

$59.17M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Nomic Bio is a biotechnology company that provides a high-throughput proteomic platform to facilitate protein measurement and custom panel development for drug discovery and biomarker identification.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Infrastructure

Keywords

proteomicshigh-throughput proteomicsprotein analysisnELISAdrug discoverytranslational researchproteomic databiological samplesprotein-level resolutionbiotech platformomicslab automationdata-driven biologysafety assessmentbio-data

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nomic Bio Comparables

Compare Nomic Bio with similar companies based on industry and business-model similarity.

Nomic Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alamar Biosciences
78%
Nautilus Biotechnology
78%
Thermo Fisher Scientific Inc.
78%

Nomic Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 17, 2024
Series ADec 8, 2021
AcceleratorMar 16, 2020
GrantApr 9, 2019

Key People

Founding team and executive leadership

Jeff Munzar

CTO, Co-founder

Founding Team

Milad Dagher

Co-Founder & CEO

Founding Team

Matt Cahill

Chief Financial Officer

Executive Team

Nomic Bio Investors

Notable investors and investment history

Nomic Bio investors
InvestorRounds
Amplitude VenturesSeries B
Lux CapitalSeries B, Series A
First Star VenturesAccelerator
BoxOne VenturesAccelerator
Real VenturesAccelerator, Series B, Series A
2048 VenturesSeries A, Accelerator
Y CombinatorAccelerator, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Will build a scalable proteomics platform together.

  • Jan 1, 2026

    Profiled over 500,000 samples across diverse applications.

Nomic Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nomic Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nomic Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontreal
Employee Range104
Year Founded2017
Last FundingSep 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.